ASP Isotopes Inc. (ASPI) is held by 1 of 149 tracked super-investor funds (144 filed in Q2) in 2026 Q2 13F filings, with 1 fund adding versus the previous quarter. Insiders were net sellers over the last 90 days ($61.8K bought vs $1.3M sold). Latest close $1.23 as of Nov 18, 2026.
Data as of Nov 18, 2026 (prices) · 2026 Q2 13F filings (quarter ended Jun 30, 2026) · Latest Form 4: Oct 16, 2026 · Congress to Nov 16, 2026.
Polen Capital Management — 1 tracked fund hold ASPI. See all holders.
Insiders bought on the open market (2 purchases, $61.8K) vs 8 sales ($1.3M). Latest buy: Sep 30, 2026. Insider trading
Orion S.A. (OEC) · Element Solutions Inc (ESI) · FLOTEK INDUSTRIES INC/CN/ (FTK) · CABOT CORP (CBT) · Merck & Co., Inc. (MRK) — stocks the same funds also hold. See all related stocks.
| Fund | Portfolio weight | Shares | Change vs prev. quarter |
|---|---|---|---|
| Polen Capital Management | 0.01% | 149,559 | ADDED (+21.6%) Q3 filed Nov 13 |
Source: SEC Form 13F filings, quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. Fund counts aggregate every share class mapped to this ticker.
Price change since quarter-end: -77.8% from the close on the first trading day after the quarter ended (Jul 1, 2026) to the latest close (Nov 17, 2026). 13F does not report purchase prices — this is the price change since the quarter-end close, not a gain on any fund’s actual purchase.
Filing season: the Q3 2026 13F tracker follows every tracked fund’s filing for the quarter ended Sep 30, 2026, with its biggest buys and sells.
Closing prices (unadjusted for dividends), last 2 years — 501 trading days to Nov 18, 2026. Dashed lines mark 13F filing deadlines. Source: Yahoo Finance daily bars.
| Institutions holding | 188 of 8,857 filers |
| Long-only filers among them | 184 |
| Change vs 2026 Q1 | +15 net · 186 entered · 171 exited |
| Shares reported, all filers | 65,402,760 |
| Reported value, all filers | $457.8M |
Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).
| Exchange | Nasdaq |
| Industry | Miscellaneous Chemical Products (SIC 2890) |
| Revenue · FY2025 | $23.8M |
| Net income · FY2025 | $-159.8M |
| Total assets · FY2025 | $498.0M |
| Shares outstanding | 153,309,380 |
| Market cap (at latest close) | $188.6M |
Source: SEC EDGAR company filings (submissions and company facts), collected Oct 30, 2026. Shares outstanding as reported Aug 14, 2026.
| Shares short · Oct 15, 2026 | 29,048,703 |
| Share of shares outstanding | 18.95% |
| Days to cover | 5.83 |
Shares short at recent settlements — Jul 31, 2026: 26.6M · Aug 14, 2026: 26.8M · Aug 31, 2026: 25.5M · Sep 15, 2026: 26.1M · Sep 30, 2026: 26.5M · Oct 15, 2026: 29.0M.
Source: FINRA Equity Short Interest (biweekly settlement data). Shares outstanding from SEC filings as of Aug 14, 2026.
| Shares failed to deliver · Oct 14, 2026 | 0 |
| Share of shares outstanding | 0.00% |
| Fails as a share of short interest · Oct 15, 2026 | 0.0% |
Fails to deliver at recent settlements — Jul 31, 2026: 2K · Aug 14, 2026: 0 · Aug 31, 2026: 14 · Sep 15, 2026: 928 · Sep 30, 2026: 222K · Oct 14, 2026: 0.
Source: SEC Fails-to-Deliver data (semi-monthly files, published about two weeks after each settlement date). Each figure is the balance of shares not yet delivered on that date; a stock absent from that date’s file counts as zero. See our research on whether fails to deliver predict returns. Shares outstanding from SEC filings as of Aug 14, 2026.
1 insider bought on the open market in the last 90 days (2 purchases, $61.8K), against 8 sales by 4 insiders ($1.3M). Latest buy: Sep 30, 2026.
Source: SEC Form 4 filings. Open-market transactions only.
| Latest open-market buy | Transaction price | Price change since disclosure |
|---|---|---|
| Ryan Robert John Andrew · 15,000 shares on Sep 30, 2026 · filed Oct 1, 2026 | $2.68 | -52.9% (close Oct 2, 2026 → Nov 17, 2026) |
Reference close is the first trading day after the filing (Oct 2, 2026). The transaction price is what the insider paid; the price change is on closing prices (dividends excluded).
Recent open-market trades
| Date | Insider | Role | Buy / Sell | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Oct 16, 2026 | Kiessling Heather | Chief Financial Officer | Sell | 21,830 | $2.19 | $47.8K | SEC filing |
| Oct 14, 2026 | Ainscow Robert | COO | Sell | 22,500 | $2.11 | $47.6K | SEC filing |
| Sep 30, 2026 | Ryan Robert John Andrew | Buy | 15,000 | $2.68 | $40.2K | SEC filing | |
| Sep 28, 2026 | Ryan Robert John Andrew | Buy | 8,000 | $2.70 | $21.6K | SEC filing | |
| Sep 8, 2026 | Ainscow Robert | COO | Sell | 8,438 | $4.29 | $36.2K | SEC filing |
| Sep 4, 2026 | Mann Paul Elliot | Chairman and CEO | Sell | 83,759 | $4.10 | $343.4K | SEC filing |
| Sep 3, 2026 | Mann Paul Elliot | Chairman and CEO | Sell | 83,758 | $3.92 | $328.3K | SEC filing |
| Sep 2, 2026 | Ainscow Donald George | EVP, Gen Counsel, Secretary | Sell | 23,678 | $3.89 | $92.1K | SEC filing |
| Sep 2, 2026 | Ainscow Robert | COO | Sell | 25,000 | $3.90 | $97.6K | SEC filing |
| Sep 2, 2026 | Mann Paul Elliot | Chairman and CEO | Sell | 83,758 | $3.91 | $327.5K | SEC filing |
Most recent open-market transactions in the same 90-day window, most recent first. Source: SEC Form 4 filings.
| Filed | Seller | Role | Shares to sell | Market value | Approx. sale date | Source |
|---|---|---|---|---|---|---|
| Sep 25, 2026 | Todd Wider | Director | 200,000 | $590.0K | Sep 25, 2026 | SEC filing |
| Sep 2, 2026 | Donald George Ainscow | Affiliate | 50,000 | $194.4K | Sep 2, 2026 | SEC filing |
| Sep 2, 2026 | Mann Paul Elliot | DIRECTOR, OFFICER | 83,758 | $316.6K | Sep 2, 2026 | SEC filing |
| Sep 2, 2026 | Ainscow Robert | OFFICER | 25,000 | $94.5K | Sep 2, 2026 | SEC filing |
| Jun 30, 2026 | Ainscow Donald George | OFFICER | 100,000 | $622.0K | Jun 30, 2026 | SEC filing |
| Jun 29, 2026 | Todd Wider | Director | 100,000 | $628.0K | Jun 29, 2026 | SEC filing |
| Jun 29, 2026 | Gorley Michael | DIRECTOR | 30,000 | $186.6K | Jun 29, 2026 | SEC filing |
| Jun 8, 2026 | Ainscow Robert | OFFICER | 8,438 | $58.1K | Jun 8, 2026 | SEC filing |
| Jun 1, 2026 | Mann Paul Elliot | DIRECTOR, OFFICER | 251,275 | $2.0M | Jun 1, 2026 | SEC filing |
| Apr 17, 2026 | Moore Duncan | DIRECTOR | 11,642 | $62.6K | Apr 16, 2026 | SEC filing |
A Form 144 notice is a planned sale, not a completed sale. Most recent first. Source: SEC Form 144 filings, 63,013 notices from Apr 13, 2023 to Oct 9, 2026.
| Filed | Filer | Form | Shares | % owned | Event date | Source |
|---|---|---|---|---|---|---|
| Apr 27, 2026 | BlackRock, Inc. | SC 13G/A | 8,274,763 | 6.6% | Mar 31, 2026 | SEC filing |
| Mar 26, 2026 | The Vanguard Group | SC 13G/A | 0 | 0.0% | Mar 13, 2026 | SEC filing |
| Feb 17, 2026 | Mann Paul Elliot | SC 13G/A | 7,759,538 | 7.0% | Dec 31, 2025 | SEC filing |
| Feb 9, 2026 | BNP Paribas Asset Management UK Ltd | SC 13G/A | 944,326 | 0.9% | Dec 31, 2025 | SEC filing |
| Jan 30, 2026 | The Vanguard Group | SC 13G | 6,406,244 | 5.8% | Dec 31, 2025 | SEC filing |
| Jan 23, 2026 | Encompass Capital Advisors LLC | SC 13G | 6,413,362 | 5.1% | Jan 16, 2026 | SEC filing |
| Nov 14, 2025 | AK Jensen Investment Management Ltd | SC 13G/A | 4,955,261 | 5.4% | Sep 30, 2025 | SEC filing |
| Aug 14, 2025 | AWM Investment Company, Inc. | SC 13G/A | 3,931,186 | 4.3% | Jun 30, 2025 | SEC filing |
| Aug 14, 2025 | AWM Investment Company, Inc. | SC 13G | 619,874 | 6.9% | Jun 30, 2025 | SEC filing |
| Apr 11, 2025 | BNP Paribas Asset Management UK Ltd | SC 13G | 3,628,215 | 5.1% | Mar 31, 2025 | SEC filing |
One filing is one row; a filing may list several reporters and the first is shown. Figures are as filed, including amendments that report zero shares after a transfer. Source: SEC Schedule 13D/G filings, 57,443 filings parsed to Oct 2, 2026.
Data unavailable — no congressional STOCK Act transactions for this ticker were parsed in the current window (as of Nov 16, 2026).
Industry: Miscellaneous Chemical Products (SIC 2890). No standing committee maps to this industry under the site’s jurisdiction rule — see Methodology.
Assignments are the current (119th Congress) rosters. A trade made in an earlier Congress may have been made under a different assignment. Jurisdiction is by industry (SEC SIC code), not by anything the company said or did. Same rule as our committee-jurisdiction study.
Red Flags
· Late Filings (NT) — Last 2 years: a late-filing notification (NT form)
Key figures
· Late Filings (NT) — Latest event: May 15, 2026 · Events in 2 yrs: 5 · Latest form: NT 10-Q
Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.
· Insider BEST — appeared in 2 of the last 20 quarterly lists; latest 2024 Q3, ranked #29 of 50.
Also held by the tracked funds that hold ASPI — ranked by lift, the co-holding pattern described in Methodology: Orion S.A. (OEC) · Element Solutions Inc (ESI) · FLOTEK INDUSTRIES INC/CN/ (FTK) · CABOT CORP (CBT) · Merck & Co., Inc. (MRK) · LINDE PLC (LIN) · ELI LILLY & Co (LLY) · PROCTER & GAMBLE Co (PG).
8 of the 8 are same-industry (SIC) fillers: fewer than 4 stocks met the lift rule for this stock.
| Filed | Items | Source |
|---|---|---|
| Oct 26, 2026 | 7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits | SEC filing |
| Oct 15, 2026 | 7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits | SEC filing |
| Oct 2, 2026 | 7.01 Regulation FD Disclosure | SEC filing |
Source: SEC EDGAR Form 8-K filings, latest first. Amendments (Form 8-K/A) are labeled as such. Item labels are the SEC's item titles; a filing can carry several items. Item 5.02 covers both departures and appointments, which this index does not distinguish.
Orion S.A. (OEC) · Track Record: how the signals scored · Practice timing on ASPI
One email a week: the week’s new filings and research. Subscribe free
Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.